Freeline Therapeutics Holdings PLC (ADR) trading halted, volatility trading pause
PremiumThe FlyFreeline Therapeutics Holdings PLC (ADR) trading halted, volatility trading pause
1y ago
Freeline announces new data from GALILEO-1 trial of FLT201
Premium
The Fly
Freeline announces new data from GALILEO-1 trial of FLT201
1y ago
Freeline downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Freeline downgraded to Neutral from Outperform at Wedbush
1y ago
Freeline expects initial clinical data from GALILEO-1 trial in Q3
PremiumThe FlyFreeline expects initial clinical data from GALILEO-1 trial in Q3
1y ago
Freeline expects cash to fund operations into 2Q24
Premium
The Fly
Freeline expects cash to fund operations into 2Q24
1y ago
Freeline reports 1H EPS (23c) vs. (95c) last year
Premium
The Fly
Freeline reports 1H EPS (23c) vs. (95c) last year
1y ago
Freeline announces proposed ADS ratio change
PremiumThe FlyFreeline announces proposed ADS ratio change
2y ago
Freeline price target lowered to $2 from $3 at BTIG
Premium
The Fly
Freeline price target lowered to $2 from $3 at BTIG
2y ago
Freeline price target lowered to $2 from $15 at H.C. Wainwright
Premium
The Fly
Freeline price target lowered to $2 from $15 at H.C. Wainwright
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100